Business Daily.
.
A+ R A-

Fluidigm Revolutionizes In Vitro Modeling for Stem Cell Researchers and Cell Biologists

E-mail Print PDF
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm (NASDAQ:FLDM) announced its Callisto system, a fully automated and programmable microfluidic cell culture system.

imageimage

Read more

Grow Your Business with Times Media
Business Daily Media